249 results on '"Paulson, Kelly G"'
Search Results
2. Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma
3. Clinical benefit of baseline imaging in Merkel cell carcinoma: Analysis of 584 patients
4. Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001-2020
5. Supplementary Figure S7 from Characterization of Immunosuppressive Myeloid Cells in Merkel Cell Carcinoma: Correlation with Resistance to PD-1 Pathway Blockade
6. Supplementary Table S3 from Characterization of Immunosuppressive Myeloid Cells in Merkel Cell Carcinoma: Correlation with Resistance to PD-1 Pathway Blockade
7. Data from Characterization of Immunosuppressive Myeloid Cells in Merkel Cell Carcinoma: Correlation with Resistance to PD-1 Pathway Blockade
8. Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma
9. Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics
10. T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
11. Characterization of immunosuppressive myeloid cells in Merkel cell carcinoma: correlation with resistance to PD-1 pathway blockade.
12. Incidence, demographics, and survival of malignant hemangioendothelioma in the United States
13. Figure S2 from Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain
14. Table S2 from Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain
15. Data from Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain
16. Supplementary Figures from Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8+ T Cells within Polyomavirus-Driven Merkel Cell Carcinomas
17. Data from Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8+ T Cells within Polyomavirus-Driven Merkel Cell Carcinomas
18. Supplementary Tables from Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8+ T Cells within Polyomavirus-Driven Merkel Cell Carcinomas
19. Data Supplement from Downregulation of MHC-I Expression Is Prevalent but Reversible in Merkel Cell Carcinoma
20. Supplementary Figures 1 - 3 from Regression of Metastatic Merkel Cell Carcinoma Following Transfer of Polyomavirus-Specific T Cells and Therapies Capable of Reinducing HLA Class-I
21. Data from Downregulation of MHC-I Expression Is Prevalent but Reversible in Merkel Cell Carcinoma
22. Data from Regression of Metastatic Merkel Cell Carcinoma Following Transfer of Polyomavirus-Specific T Cells and Therapies Capable of Reinducing HLA Class-I
23. Table S2 from Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival
24. Figure S2 from Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival
25. Supplementary Figures 1-2, Methods from Antibodies to Merkel Cell Polyomavirus T Antigen Oncoproteins Reflect Tumor Burden in Merkel Cell Carcinoma Patients
26. Data from Antibodies to Merkel Cell Polyomavirus T Antigen Oncoproteins Reflect Tumor Burden in Merkel Cell Carcinoma Patients
27. An In Vivo Model of Human Macrophages in Metastatic Melanoma
28. Systemic Immune Suppression Predicts Diminished Merkel Cell Carcinoma–Specific Survival Independent of Stage
29. Asymmetric lateral distribution of melanoma and Merkel cell carcinoma in the United States
30. Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis
31. Targeting an alternate Wilms’ tumor antigen 1 peptide bypasses immunoproteasome dependency
32. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system
33. Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma
34. Array-CGH Reveals Recurrent Genomic Changes in Merkel Cell Carcinoma Including Amplification of L-Myc
35. A faithful in vivo model of human macrophages in metastatic melanoma
36. Merkel cell carcinoma can be indolent: A case with 7 locoregional recurrences over 15 years highlights the importance of patient-tailored management
37. Effect of Host, Tumor, Diagnostic, and Treatment Variables on Outcomes in a Large Cohort With Merkel Cell Carcinoma
38. Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients
39. Pathologic nodal evaluation is increasingly commonly performed for patients with Merkel cell carcinoma
40. One in a hundred million: Merkel cell carcinoma in pediatric and young adult patients is rare but more likely to present at advanced stages based on US registry data
41. Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumab
42. Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8+ T Cells within Polyomavirus-Driven Merkel Cell Carcinomas
43. Association of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma
44. Age-Specific Incidence of Melanoma in the United States
45. Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance
46. Abstract I11: Targeting pancreatic cancer with TCR-engineered T cells
47. Reducing Head and Neck UV Exposure in Younger Persons—Millennials, Wear a Hat (or Grow Your Hair Longer)
48. Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain
49. Immunotherapy for skin cancer
50. Sarcoidosis Presenting as Isolated Anasarca and Hypercalcemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.